You are hereEvents
Using Deliberative Public Engagement To Inform Priority-Setting Decisions For Cancer Drugs
Expenditure on oncology drugs has risen faster in recent years compared to other areas of health care. The steep climb in expenditure for oncology drugs, coupled with the rising number of new cancer cases, threatens the sustainability of provincial cancer systems, and focuses attention on the economic and ethical challenges of how to maximize population health with limited resources. Increasingly, policy makers are turning to the public for guidance on finding socially acceptable responses to these challenges. This presentation focuses on the methods used and results from a series of public deliberation events in Canada on the topic of priority setting and the high cost of cancer drugs.